Supplementary Table 2. Univariate Cox proportional hazards model for prediction of MACE during follow-up in patients without obstructive CAD (n = 265) .
| Variable | Crude model (unadjusted model) | |
|---|---|---|
| HR (95%CI) | P-value | |
| Age per 1 year increase | 1.01 (0.959−1.073) | 0.612 |
| Male sex | 1.44 (0.345−6.075) | 0.613 |
| Diabetes mellitus | 9.09 (2.15−38.37) | 0.003 |
| AF | 0.04 (0.000−720.44) | 0.523 |
| CKD | 3.32 (0.823−13.40) | 0.092 |
| Suita CVD risk score | 1.07 (1.004−1.140) | 0.036 |
| CACS ＞400 | 5.80 (0.696−48.34) | 0.104 |
| Non-obstructive CAD | 3.20 (0.39−26.04) | 0.276 |
| TAPB score: T3 versus T1 and T2 | 6.13 (1.46−25.70) | 0.013 |
| Large AAP | 2.17 (0.26−18.09) | 0.472 |
| Complex AAP | 2.06 (0.248−17.19) | 0.502 |
AAP, aortic arch plaque; AF, atrial fibrillation; CAD, coronary artery disease; CACS, coronary artery calcification score; CKD, chronic kidney disease; CI, confidence interval; CVD, cardiovascular disease; MACE, major adverse cardiovascular event; TAPB, thoracic aortic plaque burden
MACE was observed in 8 patients without obstructive CAD.